Symptomatic management in multiple sclerosis

被引:11
|
作者
Shah, Pushkar [1 ]
机构
[1] South Glasgow Univ Hosp NHS Trust, Inst Neurosci, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland
关键词
Multiple sclerosis; neurology; symptoms; therapy; THC/CBD OROMUCOSAL SPRAY; TRIGEMINAL NEURALGIA; CLINICAL-FEATURES; SEXUAL DISORDERS; CONTROLLED-TRIAL; SLEEP DISORDERS; DOUBLE-BLIND; FATIGUE; SPASTICITY; TREMOR;
D O I
10.4103/0972-2327.164827
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) is the commonest cause of disability in young adults. While there is increasing choice and better treatments available for delaying disease progression, there are still, very few, effective symptomatic treatments. For many patients such as those with primary progressive MS (PPMS) and those that inevitably become secondary progressive, symptom management is the only treatment available. MS related symptoms are complex, interrelated, and can be interdependent. It requires good understanding of the condition, a holistic multidisciplinary approach, and above all, patient education and empowerment.
引用
收藏
页码:S35 / S42
页数:8
相关论文
共 50 条
  • [41] Pharmacological Management of Pain in Patients with Multiple Sclerosis
    Solaro, Claudio
    Uccelli, Michele Messmer
    DRUGS, 2010, 70 (10) : 1245 - 1254
  • [42] Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry
    Rommer, Paulus Stefan
    Eichstaedt, Kerstin
    Ellenberger, David
    Flachenecker, Peter
    Friede, Tim
    Haas, Judith
    Kleinschnitz, Christoph
    Phlau, Dieter
    Rienhoff, Otto
    Stahmann, Alexander
    Zettl, Uwe Klaus
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (12) : 1641 - 1652
  • [43] Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
    Filippini, Graziella
    Minozzi, Silvia
    Borrelli, Francesca
    Cinquini, Michela
    Dwan, Kerry
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (05):
  • [44] Fatigue in multiple sclerosis - Insights into evaluation and management
    Ayache, Samar S.
    Chalah, Moussa A.
    NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2017, 47 (02): : 139 - 171
  • [45] THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis
    Sastre-Garriga, Jaume
    Vila, Carlos
    Clissold, Stephen
    Montalban, Xavier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (05) : 627 - 637
  • [46] Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes
    Racke, Michael K.
    Frohman, Elliot M.
    Frohman, Teresa
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [47] Cannabis and multiple sclerosis
    Fragoso, Yara Dadalti
    Carra, Adriana
    Macias, Miguel Angel
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (08) : 849 - 854
  • [48] Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Symptom Management and Vaccination
    Al Thubaiti, Ibtisam A.
    AlKhawajah, Mona M.
    Al Fugham, Norah
    Alissa, Dema A.
    Al-Jedai, Ahmed H.
    Al Malik, Yaser M.
    Almejally, Mousa A.
    Al-Mudaiheem, Hajer Y.
    Al-Omari, Bedor A.
    AlOtaibi, Hessa S.
    Al Yafeai, Rumaiza H.
    Babakkor, Mohammed A.
    Bunyan, Reem F.
    Cupler, Edward J.
    Hakami, Mohammed
    Kedah, Hanaa M.
    Makkawi, Seraj
    Saeed, Leena H.
    Saeedi, Jameelah A.
    Shosha, Eslam
    Al Jumah, Mohammed A.
    CLINICAL AND TRANSLATIONAL NEUROSCIENCE, 2023, 7 (01)
  • [49] Fatigue Management in Multiple Sclerosis
    Carmen Tur
    Current Treatment Options in Neurology, 2016, 18
  • [50] Ontology for Symptomatic Treatment of Multiple Sclerosis
    Esfahani, Misagh Zahiri
    Ahmadi, Maryam
    Adibi, Iman
    HEALTHCARE INFORMATICS RESEARCH, 2022, 28 (04) : 332 - 342